Clinical Trial: EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07819071) titled 'EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS' on Sept. 04.

Brief Summary: The aim of this study is to evaluate the tolerance and efficacy of a new emollient cream specifically dedicated to the eyelid area when applied in association with tacrolimus 0.1% in subjects suffering from eyelid Atopic Dermatitis.

Study Start Date: Nov. 03, 2025

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis (AD)

Intervention: OTHER: Tested Emollient RV5258A

Topical application of the investigational eye contour emollient on one randomized eyelid over a 2-week treatmen...